• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.麦胶蛋白肽的肠上皮转运和脱酰胺作用:乳糜泻患者免疫球蛋白 A 的作用。
Clin Exp Immunol. 2011 Apr;164(1):127-36. doi: 10.1111/j.1365-2249.2010.04317.x. Epub 2011 Jan 14.
2
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.体外麦醇溶蛋白激发后乳糜泻自身抗体的分泌取决于小肠黏膜转谷氨酰胺酶2特异性IgA沉积。
BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.
3
Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.组织转谷氨酰胺酶在乳糜泻中对麦醇溶蛋白T细胞表位的选择。酶特异性和pH对转酰胺基与脱酰胺基过程的影响。
J Biol Chem. 2002 Sep 13;277(37):34109-16. doi: 10.1074/jbc.M204521200. Epub 2002 Jul 1.
4
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.γ-麦谷蛋白特异性麸质相关疾病抗体以交叉反应的方式识别脱酰胺化相关的 p31-43 和 p57-68α麦谷蛋白肽。
Amino Acids. 2021 Jul;53(7):1051-1063. doi: 10.1007/s00726-021-03006-7. Epub 2021 May 31.
5
Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?麸质酶 2 自身抗体在乳糜泻中的作用:除了诊断工具,还是致病因素?
Autoimmun Rev. 2010 Sep;9(11):744-9. doi: 10.1016/j.autrev.2010.06.003. Epub 2010 Jun 12.
6
Unexpected role of surface transglutaminase type II in celiac disease.组织转谷氨酰胺酶II在乳糜泻中的意外作用。
Gastroenterology. 2005 Nov;129(5):1400-13. doi: 10.1053/j.gastro.2005.07.054.
7
Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.麸质酶 2 和麸质酶 2 自身抗体在乳糜泻中的研究进展。
Clin Rev Allergy Immunol. 2019 Aug;57(1):23-38. doi: 10.1007/s12016-016-8557-4.
8
Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.转谷氨酰胺酶对麦醇溶蛋白肽的脱酰胺和交联作用及其与乳糜泻的关系。
Biochim Biophys Acta. 2004 Nov 5;1690(3):220-30. doi: 10.1016/j.bbadis.2004.06.009.
9
Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.血清自身抗体针对转谷氨酰胺酶-2的亲和力低于乳糜泻患者针对麦胶蛋白的同种异体抗体。
Clin Exp Immunol. 2014 Jul;177(1):86-93. doi: 10.1111/cei.12302.
10
Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.麦醇溶蛋白 p31-43 肽在肠上皮细胞和乳糜泻黏膜中的溶酶体积累诱导氧化应激和组织转谷氨酰胺酶介导的过氧化物酶体增殖物激活受体 γ 下调。
Gut. 2010 Mar;59(3):311-9. doi: 10.1136/gut.2009.183608. Epub 2009 Dec 1.

引用本文的文献

1
Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease-In Vitro Studies in Intestinal Cells and Duodenal Biopsies.转谷氨酰胺酶 2 抑制作为乳糜泻治疗策略的研究——肠道细胞和十二指肠活检的体外研究。
Int J Mol Sci. 2023 Mar 1;24(5):4795. doi: 10.3390/ijms24054795.
2
Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.2 型转谷氨酰胺酶在乳糜泻中的作用:发病机制、诊断和治疗的关键因素。
Int J Mol Sci. 2022 Jul 6;23(14):7513. doi: 10.3390/ijms23147513.
3
Current and emerging therapies for coeliac disease.目前和新兴的乳糜泻治疗方法。
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):181-195. doi: 10.1038/s41575-020-00378-1. Epub 2020 Nov 20.
4
Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.乳糜泻发病机制:一种众所周知的免疫介导疾病的不确定性。
Front Immunol. 2020 Jul 8;11:1374. doi: 10.3389/fimmu.2020.01374. eCollection 2020.
5
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.2 型转谷氨酰胺酶(TG2)、麦胶蛋白肽 31-43 与乳糜泻中抗 TG2 抗体的相互作用。
Int J Mol Sci. 2020 May 23;21(10):3673. doi: 10.3390/ijms21103673.
6
Novel Nondietary Therapies for Celiac Disease.新型非饮食疗法治疗乳糜泻。
Cell Mol Gastroenterol Hepatol. 2019;8(3):335-345. doi: 10.1016/j.jcmgh.2019.04.017. Epub 2019 May 27.
7
Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies.乳糜泻:发病机制、预防及新型疗法的当前概念综述
Front Pediatr. 2018 Nov 21;6:350. doi: 10.3389/fped.2018.00350. eCollection 2018.
8
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.囊性纤维化跨膜电导调节因子在乳糜泻中的致病作用。
EMBO J. 2019 Jan 15;38(2). doi: 10.15252/embj.2018100101. Epub 2018 Nov 29.
9
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.抗 2 型转谷氨酰胺酶抗体作为 2 型转谷氨酰胺酶功能的调节剂:在乳糜泻中的可能病理作用。
Cell Mol Life Sci. 2018 Nov;75(22):4107-4124. doi: 10.1007/s00018-018-2902-0. Epub 2018 Aug 22.
10
Transcription Factor Binding Site Enrichment Analysis in Co-Expression Modules in Celiac Disease.乳糜泻共表达模块中的转录因子结合位点富集分析
Genes (Basel). 2018 May 10;9(5):245. doi: 10.3390/genes9050245.

本文引用的文献

1
Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia.靶向 TG3 和 TG6 的麸质 T 细胞表位;对疱疹样皮炎和麸质相关性共济失调的影响。
Amino Acids. 2010 Nov;39(5):1183-91. doi: 10.1007/s00726-010-0554-y. Epub 2010 Mar 19.
2
Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.转谷氨酰胺酶 2 表达并在人单核细胞衍生的树突状细胞和巨噬细胞表面具有活性。
Immunol Lett. 2010 May 4;130(1-2):74-81. doi: 10.1016/j.imlet.2009.12.010. Epub 2010 Feb 10.
3
Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.麦醇溶蛋白 p31-43 肽在肠上皮细胞和乳糜泻黏膜中的溶酶体积累诱导氧化应激和组织转谷氨酰胺酶介导的过氧化物酶体增殖物激活受体 γ 下调。
Gut. 2010 Mar;59(3):311-9. doi: 10.1136/gut.2009.183608. Epub 2009 Dec 1.
4
Tissue-mediated control of immunopathology in coeliac disease.乳糜泻中组织介导的免疫病理学控制
Nat Rev Immunol. 2009 Dec;9(12):858-70. doi: 10.1038/nri2670.
5
Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.乳糜泻IgA通过转谷氨酰胺酶2和RhoA的活性在体外调节血管通透性。
Cell Mol Life Sci. 2009 Oct;66(20):3375-85. doi: 10.1007/s00018-009-0116-1. Epub 2009 Aug 13.
6
Endocytotic segregation of gliadin peptide 31-49 in enterocytes.肠上皮细胞中麦醇溶蛋白肽 31-49 的内吞分离。
Gut. 2010 Mar;59(3):300-10. doi: 10.1136/gut.2008.169656. Epub 2009 Aug 3.
7
Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.由麸质刺激的乳糜泻特异性肠道T细胞释放的干扰素-γ增强了麸质肽的跨上皮通量。
J Pharmacol Exp Ther. 2009 May;329(2):657-68. doi: 10.1124/jpet.108.148007. Epub 2009 Feb 13.
8
Synthesis of potent water-soluble tissue transglutaminase inhibitors.强效水溶性组织转谷氨酰胺酶抑制剂的合成
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5559-62. doi: 10.1016/j.bmcl.2008.09.006. Epub 2008 Sep 6.
9
The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.单克隆抗体6B9识别CD44而非细胞表面转谷氨酰胺酶2。
Scand J Immunol. 2008 Nov;68(5):534-42. doi: 10.1111/j.1365-3083.2008.02173.x. Epub 2008 Sep 18.
10
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture.活性益生菌乳酸双歧杆菌可抑制小麦醇溶蛋白在上皮细胞培养中诱导的毒性作用。
Clin Exp Immunol. 2008 Jun;152(3):552-8. doi: 10.1111/j.1365-2249.2008.03635.x. Epub 2008 Apr 16.

麦胶蛋白肽的肠上皮转运和脱酰胺作用:乳糜泻患者免疫球蛋白 A 的作用。

Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.

机构信息

Paediatric Research Centre, Medical School, University of Tampere, Tampere 33014, Finland.

出版信息

Clin Exp Immunol. 2011 Apr;164(1):127-36. doi: 10.1111/j.1365-2249.2010.04317.x. Epub 2011 Jan 14.

DOI:10.1111/j.1365-2249.2010.04317.x
PMID:21235541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3074225/
Abstract

In coeliac disease, the intake of dietary gluten induces small-bowel mucosal damage and the production of immunoglobulin (Ig)A class autoantibodies against transglutaminase 2 (TG2). We examined the effect of coeliac patient IgA on the apical-to-basal passage of gluten-derived gliadin peptides p31-43 and p57-68 in intestinal epithelial cells. We demonstrate that coeliac IgA enhances the passage of gliadin peptides, which could be abolished by inhibition of TG2 enzymatic activity. Moreover, we also found that both the apical and the basal cell culture media containing the immunogenic gliadin peptides were able to induce the proliferation of deamidation-dependent coeliac patient-derived T cells even in the absence of exogenous TG2. Our results suggest that coeliac patient IgA could play a role in the transepithelial passage of gliadin peptides, a process during which they might be deamidated.

摘要

在乳糜泻中,膳食 gluten 的摄入会导致小肠黏膜损伤,并产生针对转谷氨酰胺酶 2 (TG2) 的免疫球蛋白 (Ig)A 类自身抗体。我们研究了乳糜泻患者 IgA 对肠上皮细胞中 gluten 衍生的gliadin 肽 p31-43 和 p57-68 从顶端到基底的传递的影响。我们证明乳糜泻 IgA 增强了 gliadin 肽的传递,而这一传递可以通过抑制 TG2 酶活性来消除。此外,我们还发现,含有免疫原性 gliadin 肽的顶端和基底细胞培养基都能够诱导脱酰胺依赖性乳糜泻患者源性 T 细胞的增殖,即使没有外源性 TG2 也是如此。我们的结果表明,乳糜泻患者 IgA 可能在 gliadin 肽的跨上皮传递中发挥作用,在此过程中它们可能被脱酰胺。